Disclosure Of Entity's Operating Segments [Text Block]

Oxford Biomedica PLC - Filing #5873328

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
12 8,7 97 GBP
89 ,53 9 GBP
Tax expense (income)
1 ,34 4 GBP
4,3 65 GBP
Profit (loss) before tax
4 7,2 65 GBP
18 8,5 27 GBP
Profit (loss)
5,4 19 GBP
- GBP
4 8,6 09 GBP
- GBP
- GBP
- GBP
- GBP
43 ,1 90 GBP
4 3,1 90 GBP
- GBP
- GBP
18 4,1 62 GBP
2 6,6 72 GBP
- GBP
- GBP
- GBP
157 ,4 90 GBP
15 7,4 90 GBP
Cash flows from (used in) operating activities
5 0,6 66 GBP
28 ,5 17 GBP
Cash flows from (used in) investing activities
5, 632 GBP
2 ,80 6 GBP
Cash flows from (used in) financing activities
2, 908 GBP
12 ,70 3 GBP
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.